Sweden approves copy of GSK asthma blockbuster – FiercePharma

Sweden approves copy of GSK asthma blockbuster
FiercePharma
Swedish regulators have approved a knock-off version of the asthma drug, which brought in more than $8 billion in 2010 sales for GSK, paving the way for it to be sold in Germany, Italy, Portugal, Hungary and the Czech and Slovak Republics,
Glaxo's Advair Faces Sales Decline on Swedish Generic ApprovalBloomberg
Glaxo's Advair Faces Sales Decline on Swedish Generic ApprovalSan Francisco Chronicle

all 4 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *